Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hagens Berman Reminds Omnicell (OMCL) Investors of Lead Plaintiff Deadline, Encourages Investors Who Lost $50,000+ to Contact the Firm

OMCL

SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in the securities class action, Bursick v. Omnicell, Inc. et al., No. 3:19cv04150, pending in the U.S. District Court for the Northern District of California.

If you invested in Omnicell between October 25, 2018 and July 11, 2019 (the “Class Period”) and suffered significant losses (in excess of $50,000), you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.

If you wish to serve as a lead plaintiff in this class action, you must move the Court no later than September 16, 2019 (the “Lead Plaintiff deadline”).  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/investor-fraud/omnicell

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

OMCL@hbsslaw.com.

According to the Complaint, Defendants misled investors by concealing that Omnicell (1) engaged in improper revenue recognition, (2) experienced weaker demand for new product lines than it previously projected, (3) would be required to write off certain obsolete inventory, and (4) misclassified certain expenses as capitalized expenditures.

“We’re focused on investors’ losses, whether Omnicell and senior management engaged in accounting misconduct,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Omnicell should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email OMCL@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

Primary Logo